In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Carbital 90 Drug Master File in Korea (Carbital 90 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Carbital 90. The MFDS reviews the Carbital 90 KDMF as part of the drug registration process and uses the information provided in the Carbital 90 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Carbital 90 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Carbital 90 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Carbital 90 suppliers with KDMF on PharmaCompass.